Domainex is sponsoring, Discovery Technologies 2021, which will explore evolving early drug discovery technologies by focusing on three core themes:

• Emerging Screening Strategies: will delve into a broad range of topics showcasing the innovative approaches being applied across early drug discovery endeavours.  Areas for discussion will include CRISPR for target identification, the integration of AI, emerging screening paradigms and new therapeutic modalities amongst many others.
• Mass Spectrometry & Biophysical Approaches in Early Drug Discovery: the application of direct detection MS techniques and biophysical approaches early in discovery is providing projects with rapid access to more reliable chemical equity faster. This session explores the implementation of these tools in a variety of applications including ASMS, covalent compound screening and cell-based MS.
• Hit Triage: the success of Hit and Lead Discovery is defined by the quality of the equity they can identify whilst the pitfalls to waylay unsuspecting project teams are numerous.  Many undesirable mechanisms exist to bloat hit outputs and obscure the starting points projects really need to focus on. This session will examine what the issues are and the strategies being adopted to deal with them.